Advertisement ev3 names new senior vice president and CFO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

ev3 names new senior vice president and CFO

ev3, an endovascular device company, has appointed Shawn McCormick as its new senior vice president and CFO, effective January 19, 2009.

Mr McCormick succeeds Patrick Spangler, who has resigned as senior vice president and CFO, effective January 19, 2009.

Most recently, Mr McCormick served as vice president of corporate development at Medtronic. Mr McCormick has earned his MBA from the University of Minnesota’s Carlson School of Management and his BS in accounting from Arizona State University.

Robert Palmisano, president and CEO of ev3, said: “We are very pleased to have someone with Shawn’s experience join the ev3 management team. His proven track record in financial management and business development will add tremendous value as we continue to focus on expanding our position in the peripheral vascular and neurovascular markets and delivering increased shareholder value.

“I would also like to thank Pat Spangler for his many contributions to ev3 over the past three and a half years. We wish him success in his future endeavors.”